Posts by: Vanessa Pataia

Vanessa Pataia

May 26, 2020May 26, 2020

ALD Testing Should Be Done in Males with Primary Adrenal Insufficiency of Unknown Cause, Case Report Contends

News

Lack of testing for adrenoleukodystrophy (ALD) in males who have primary adrenal insufficiency due to an unknown cause may lead to a delayed or missing diagnosis of ALD. That finding ... Read more

January 14, 2020January 14, 2020

Potential X-ALD Oral Therapy, Leriglitazone, Put on Fast Track by FDA

News

Leriglitazone, a potential therapy for X-linked adrenoleukodystrophy (X-ALD), has been put on a fast track for review and possible approval by the U.S. Food and Drug Administration (FDA). Leriglitazone, also ... Read more